Related Experiment Video
Updated: Aug 14, 2026
Legionella pneumophila Outer Membrane Vesicles: Isolation and Analysis of Their Pro-inflammatory Potential on Macrophages
Published on: February 22, 2017
Elevated formation of lipoxins in viral antibody-positive rat alveolar macrophages
1Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, 19104-6085.
Abstract:
Alveolar macrophages (AM) obtained both from specific viral antibody-positive (VA+) rats and from specific viral antibody-negative (VA-) rats were compared for their respective capacity to produce lipoxins (LX) in a given experimental condition. Both cell preparations were incubated with (15S), 15-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid (15-HETE) in the presence of calcium ionophore A23187. The reaction mixtures were extracted and chromatographed on reverse-phase high performance liquid chromatography (RP-HPLC). Profiles of LX formation in each group were evaluated on the basis of chromatographic behavior, UV spectral characteristics (lambda max at 301 nm with shoulders at 289 nm and 317 nm), and co-elution with synthetic lipoxin A4 (LXA4) and lipoxin B4 (LXB4) standards as well as with authentic materials. The AM harvested from VA+ rats (AM-VA+) produced consistently detectable levels of LX (i.e., LXA4 and LXB4), whereas the AM from VA- rats (AM-VA-) produced no detectable LX under the same experimental condition. These results offer a possibility that elevated capacity of the AM-VA+ to produce LX may be associated with previous exposures to selected specific viral pathogens and/or with viral infections. Considering the distinct biologic properties of LX, the apparent production of the enhanced levels of LX as shown in this model system may play an important role in both pathophysiology and immunoregulatory network in virus-induced pulmonary disorder.
Insights
Alveolar macrophages from virus-exposed rats produced lipoxins (LX), while those from non-exposed rats did not. This suggests viral infections may enhance LX production in lung immunity.
Area of Science:
- Immunology
- Pulmonary Medicine
- Lipid Mediators
Background:
- Alveolar macrophages (AM) play a crucial role in lung immunity.
- Lipoxins (LX) are anti-inflammatory eicosanoids with immunomodulatory functions.
- The impact of viral infections on LX production by AM is not fully understood.
Purpose of the Study:
- To compare the lipoxin (LX) production capacity of alveolar macrophages (AM) from viral antibody-positive (VA+) and viral antibody-negative (VA-) rats.
- To investigate the potential association between viral exposure and enhanced LX synthesis in AM.
- To explore the role of LX in virus-induced pulmonary disorders.
Main Methods:
- Alveolar macrophages (AM) were isolated from VA+ and VA- rats.
- AM were incubated with 15-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid (15-HETE) and calcium ionophore A23187.
- Lipoxin production was analyzed using reverse-phase high-performance liquid chromatography (RP-HPLC), UV spectroscopy, and co-elution with standards (LXA4, LXB4).
Main Results:
- AM from VA+ rats (AM-VA+) produced detectable levels of lipoxins (LXA4 and LXB4).
- AM from VA- rats (AM-VA-) did not produce detectable levels of LX under the same conditions.
- These findings indicate a differential capacity for LX production based on viral antibody status.
Conclusions:
- Previous exposure to specific viral pathogens or active viral infections may enhance the capacity of alveolar macrophages (AM) to produce lipoxins (LX).
- The elevated LX production observed in AM-VA+ rats suggests a potential role for LX in the pathophysiology and immunoregulatory networks of virus-induced pulmonary disorders.
- This study highlights a novel link between viral exposure and lipoxin biosynthesis in the lung.
